Quest PharmaTech Inc. QPTFF
OTC PK
| 07/31/2026 | 04/30/2026 | 01/31/2026 | 10/31/2025 | 07/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -4.86% | -4.39% | -4.20% | -21.73% | -21.60% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -13.68% | -11.76% | -13.37% | -14.04% | -3.63% |
| Operating Income | 13.68% | 11.76% | 13.37% | 14.04% | 3.63% |
| Income Before Tax | 534.97% | 2,229.24% | 381.40% | 96.51% | 62.25% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 534.97% | 2,229.24% | 381.40% | 96.51% | 62.25% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 534.97% | 2,229.24% | 381.40% | 96.51% | 62.25% |
| EBIT | 13.68% | 11.76% | 13.37% | 14.04% | 3.63% |
| EBITDA | -- | -- | -- | 70.31% | 36.83% |
| EPS Basic | 540.43% | 2,487.50% | 382.67% | 96.74% | 62.99% |
| Normalized Basic EPS | 296.43% | 492.86% | 266.67% | 121.05% | 46.15% |
| EPS Diluted | 540.43% | 2,487.50% | 382.67% | 96.74% | 62.99% |
| Normalized Diluted EPS | 296.43% | 492.86% | 266.67% | 121.05% | 46.15% |
| Average Basic Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Average Diluted Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |